Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Ireland urges people not to stockpile medicines ahead of Brexit
DUBLIN (Reuters) - Ireland’s deputy prime minister on Tuesday called on people not to stockpile medicine before Britain quits the European Union, saying the country had at least eight weeks ...
Japan approves world-first trial using iPS cells to treat spinal cord injuries
The health ministry on Monday approved the world’s first clinical test in which artificially derived stem cells will be used to treat patients with spinal cord injuries.
Intercept Announces Positive Topline Results from Pivotal Phase 3 REGENERATE Study of Obeticholic Acid in Patients with Liver Fibrosis Due to NASH
NEW YORK, Feb.
Experimental Anti-Aging Treatment That Kills Old Cells Has Passed First Human Trial
Not all damaged cells die.
Physicists pinpoint a simple mechanism that makes bacteria resistant to antibiotics
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into ho...
Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis
NIH-funded study found Neuromelanin-sensitive MRI able to measure dopamine function associated with psychosisResearchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sen...
Innovate UK awards AKLRD £675,000 for osteoarthritis drug
AKL Research and Development’s (AKLRD) early-stage osteoarthritis drug has won a prestigious award from Innovate UK, as a potential “game-changing” treatment.
Darolutamide shows promise for treatment of prostate cancer
Orion's and Bayer's darolutamide has shown substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial.
Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder
Valby, Denmark and Tokyo, Japan, 14 February 2019 -- H.
Experimental 'nano-painkiller' is more effective than morphine but has low addiction risk, scientists discover
Driven by opioid addictions, more than 70,000 Americns died of drug overdoses in 2017.
Swayed by discounts, NICE finally backs Roche's Perjeta for postsurgery breast cancer
Looks like the third time was a charm for Roche’s Perjeta when it comes to postsurgery treatment of HER2-positive breast cancer in England.
Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients
(Reuters) - Nektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and Bristol-Myers Squibb Co’s immunotherapy...
388
389
390
391
392
393
394
395
396
